Back to User profile » Professor In-Wha Kim
Papers published by Professor In-Wha Kim:
Adverse Events Related to Off-Label Drugs Using Spontaneous Adverse Event Reporting Systems
Han N, Oh JM, Kim IW
Therapeutics and Clinical Risk Management 2021, 17:877-887
Published Date: 21 August 2021
Impact of depression on change in coronary heart disease risk status: the Korean Genome and Epidemiology Study (KoGES)
Jang HY, Song YK, Kim JH, Kim MG, Han N, Lee HY, Kim IW, Oh JM
Therapeutics and Clinical Risk Management 2018, 14:121-128
Published Date: 10 January 2018
Effect of additive calcium administration on FGF23 levels in patients with mild chronic kidney disease treated with calcitriol: a randomized, open-labeled clinical trial
Han N, Hong SH, Kim YS, Kim DK, Kim IW, Ji E, Oh JM
Therapeutics and Clinical Risk Management 2017, 13:999-1007
Published Date: 14 August 2017
Meta-analysis of the impact of thioprine S-methyltransferase polymorphisms on the tolerable 6-mercaptopurine dose considering initial dose and ethnic difference
Kim MG, Ko M, Kim IW, Oh JM
OncoTargets and Therapy 2016, 9:7133-7139
Published Date: 18 November 2016
Genetic polymorphisms of CASR and cancer risk: evidence from meta-analysis and HuGE review
Jeong S, Kim JH, Kim MG, Han N, Kim IW, Kim T, Oh JM
OncoTargets and Therapy 2016, 9:655-669
Published Date: 9 February 2016